Stephens v. Corizon of Florida, LLC.

CourtDistrict Court, M.D. Florida
DecidedJuly 14, 2021
Docket3:20-cv-00070
StatusUnknown

This text of Stephens v. Corizon of Florida, LLC. (Stephens v. Corizon of Florida, LLC.) is published on Counsel Stack Legal Research, covering District Court, M.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Stephens v. Corizon of Florida, LLC., (M.D. Fla. 2021).

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA JACKSONVILLE DIVISION

WILLIAM T. STEPHENS,

Plaintiff,

vs. Case No.: 3:20-cv-70-BJD-PDB

CORIZON, LLC, et al.,

Defendants. /

ORDER ON MOTION TO DISMISS I. Status Plaintiff William T. Stephens, an inmate in the custody of the Florida Department of Corrections (FDOC), initiated this action on January 24, 2020,1 by filing a pro se Civil Rights Complaint under 42 U.S.C. § 1983. (Doc. 1, Complaint). He is proceeding on an Amended Complaint (Doc. 16, Am. Compl.), which he filed through court-appointed counsel on December 9, 2020. He sues FDOC and two medical service contractors: Corizon, LLC (“Corizon”), and Centurion of Florida, LLC (“Centurion”). Plaintiff alleges that because of a cost- saving policy, FDOC, Corizon, and Centurion failed to provide him lifesaving treatment for Hepatitis C, in violation of the Eighth Amendment, the Americans With Disabilities Act (ADA), and the Rehabilitation Act of 1973.

1 See Houston v. Lack, 487 U.S. 266, 276 (1988) (mailbox rule). Before the Court are the Defendants’ motions to dismiss the Amended Complaint. (Doc. 36, Centurion Motion; Doc. 37, FDOC Motion; Doc. 40, Corizon

Motion). Defendants argue that Plaintiff failed to exhaust available administrative remedies. Centurion also argues that Plaintiff failed to state a claim for relief because he has not alleged facts showing (1) that Centurion had a policy or custom of denying treatment to inmates with HCV or (2) that any

policy or custom of Centurion was the “moving force” behind a constitutional violation.2 Plaintiff responded in opposition. (Doc. 42, Response to Motions to Dismiss). FDOC filed a reply (Doc. 47, FDOC’s Reply), and Plaintiff filed a sur- reply (Doc. 50, Plaintiff’s Sur-Reply). The motions are ripe for review.

II. Plaintiff’s Allegations3

Hepatitis C is a blood-borne disease caused by the Hepatitis C virus (HCV). HCV primarily affects the liver, and if left untreated it can lead to serious illness or death. Am. Compl., ¶¶ 15–21. Chronic HCV can cause fibrosis of the liver, which occurs when scar tissue replaces healthy liver tissue. Over

time, the scar tissue – or fibrosis – can take over most of the liver, at which point the fibrosis is termed “cirrhosis.” Id., ¶ 19. Extensive scarring of the liver

2 Centurion also moved to stay proceedings pending resolution of the motions to dismiss (Doc. 38, Motion to Stay), and Plaintiff responded (Doc. 43, Response to Motion to Stay).

3 Because this case is before the Court on Defendants’ motions to dismiss, the Court accepts the complaint’s allegations as true and construes them in the light most favorable to the plaintiff. Cinotto v. Delta Air Lines, Inc., 674 F.3d 1285, 1291 (11th Cir. 2012). may not only cause additional complications like kidney disease, but it can also increase the risk of liver cancer. People who have human immunodeficiency

virus (HIV) in addition to HCV are at higher risk of rapidly developing liver disease. Id., ¶ 22. According to one study, “delaying treatment for a person with HCV and HIV until they have cirrhosis increases their risk of liver related mortality by five times.” Id., ¶ 23.

In 2013, a new type of drug emerged for treating HCV, called a direct- acting antiviral (DAA). Id., ¶ 24. DAA’s are oral medications that have few side effects and are over 95% effective at curing HCV. Id., ¶ 25. DAA therapy has been part of the standard of care for treating HCV patients since 2014, following

guidance issued by the American Association for the Study of Liver Diseases (AASLD) and the Infectious Disease Society of America (IDSA). Id., ¶¶ 26–31. Plaintiff was long ago diagnosed with both HCV and HIV. See id., ¶¶ 40, 42. FDOC has known (or should have known) Plaintiff had HCV and HIV since

he was taken into FDOC custody in 2007. Id., ¶ 40. Plaintiff alleges that FDOC’s medical service providers – Corizon and Centurion – knew or should have known he had these conditions as well. See id., ¶¶ 42, 64, 72. From 2013, when DAA’s became available, until October 2017, FDOC and its medical contractors

failed to provide DAA’s to Plaintiff and thousands of other HCV-positive inmates. Id., ¶¶ 32–33. Plaintiff alleges that FDOC, Corizon, and Centurion failed to offer DAA therapy despite knowing about DAA’s and despite knowing that DAA therapy was part of the standard of care for treating HCV. Id., ¶¶ 32, 35–37, 48–50. According to Plaintiff, from 2013 to 2016, FDOC and Corizon

refused to provide DAA’s to him and other inmates because FDOC and Corizon wanted to reduce costs and increase the contractor’s profits. See id., ¶¶ 35–46. Plaintiff alleges that FDOC and Centurion continued the same policy after Centurion took over as FDOC’s medical service provider in May 2016. See id.,

¶¶ 47–57. Plaintiff states that FDOC and Centurion provided him DAA’s only in October 2017, when FDOC and Centurion were sued in federal court over their failure to treat inmates who had HCV. Id., ¶¶ 34, 54. Plaintiff asserts that Defendants’ delay in treating his HCV “caused his

quality of life to substantially deteriorate, and has caused permanent liver damage.” Id., ¶ 58. Plaintiff is “at heightened risk for developing further symptoms [of HCV] including further advanced liver failure, liver cancer, and death.” Id., ¶ 59. According to Plaintiff, “[t]he willful and deliberate acts of

Defendants FDC, Corizon, and Centurion, in withholding HCV treatment for Mr. Stephens, have caused him great physical pain and mental discomfort in his daily activities of living. It has shortened his lifespan and has caused him severe emotional pain and suffering.” Id., ¶ 60.

Based on these facts, Plaintiff asserts four claims in the Amended Complaint. In Counts One and Two, he alleges that Corizon and Centurion, respectively, were deliberately indifferent to a serious medical need because they denied him necessary treatment for chronic HCV, in violation of the Eighth Amendment. Am. Compl. ¶¶ 61–68 (Count One), ¶¶ 69–76 (Count Two). In

Count Three, Plaintiff asserts that FDOC discriminated against him based on his disability because it withheld medical treatment for HCV but did not withhold treatment from prisoners who had other disabilities or who were not disabled. Id., ¶¶ 77–93. Finally, in Count Four, Plaintiff alleges that FDOC

violated the Rehabilitation Act by excluding him from receiving HCV treatment solely by reason of his disability. Id., ¶¶ 94–102. Plaintiff seeks a declaration that Corizon and Centurion violated Plaintiff’s rights under the Eighth Amendment and that FDOC violated Plaintiff’s rights under the ADA and the

Rehabilitation Act. Plaintiff also seeks compensatory damages against all Defendants, punitive damages against Corizon and Centurion, attorneys’ fees and costs, and any other appropriate relief.

III. Parties’ Positions on Exhaustion The threshold issue in this case is exhaustion. Each Defendant argues

that Plaintiff failed to exhaust administrative remedies before filing the § 1983 lawsuit, as required by the Prison Litigation Reform Act (PLRA). Centurion Motion at 2, 6–9; FDOC Motion at 1, 3–6; Corizon Motion at 4–7. Specifically, Defendants argue that Plaintiff failed to comply with the time constraints

imposed by FDOC’s grievance procedures. FDOC submits records showing that on March 16, 2018, Centurion began to administer a 12-week DAA treatment regimen to Plaintiff. FDOC Motion at

2; (Doc. 37-2, FDOC Exhibit 2). Centurion used a drug called Epclusa.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Harper v. Jenkin
179 F.3d 1311 (Eleventh Circuit, 1999)
Jim E. Chandler v. James Crosby
379 F.3d 1278 (Eleventh Circuit, 2004)
David Johnson v. Tydus Meadows
418 F.3d 1152 (Eleventh Circuit, 2005)
Goebert v. Lee County
510 F.3d 1312 (Eleventh Circuit, 2007)
National Labor Relations Board v. Goya Foods
525 F.3d 1117 (Eleventh Circuit, 2008)
Bryant v. Rich
530 F.3d 1368 (Eleventh Circuit, 2008)
Turner v. Burnside
541 F.3d 1077 (Eleventh Circuit, 2008)
Houston v. Lack
487 U.S. 266 (Supreme Court, 1988)
Dole v. United Steelworkers
494 U.S. 26 (Supreme Court, 1990)
Woodford v. Ngo
548 U.S. 81 (Supreme Court, 2006)
Jones v. Bock
549 U.S. 199 (Supreme Court, 2007)
Parzyck v. Prison Health Services, Inc.
627 F.3d 1215 (Eleventh Circuit, 2010)
Cinotto v. Delta Air Lines, Inc.
674 F.3d 1285 (Eleventh Circuit, 2012)
Hearndon v. Graham
767 So. 2d 1179 (Supreme Court of Florida, 2000)
City of Miami v. Brooks
70 So. 2d 306 (Supreme Court of Florida, 1954)
White v. Moore
789 So. 2d 1118 (District Court of Appeal of Florida, 2001)
Davis v. Monahan
832 So. 2d 708 (Supreme Court of Florida, 2002)
Hillsborough Community Mental Health Ctr. v. Harr
618 So. 2d 187 (Supreme Court of Florida, 1993)
Moliere Dimanche, Jr. v. Jerry Brown
783 F.3d 1204 (Eleventh Circuit, 2015)
Shawn Wayne Whatley v. Warden, Ware State Prison
802 F.3d 1205 (Eleventh Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
Stephens v. Corizon of Florida, LLC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/stephens-v-corizon-of-florida-llc-flmd-2021.